Its interaction with cathepsin B promotes cellular migration and invasion via activating MMP9 and urokinase-type plasminogen activator (uPA), enhancing tumor-induced vascularization of endothelial cells and activation of MAPK/AKT Signaling (Chen et al., 2012). This evidence concerns the gene PLAU and neoplasm.